Sentences with phrase «human stem cell sources»

Not exact matches

The difficulties associated with obtaining nerve tissue at the correct stage of development and differentiation from aborted embryos means that foetal tissue transplantation is no longer in favour, but the creation of human embryos specifically as sources of stem cells, and the push to use «spare» embryos from IVF treatments is gatheringmomentum.

Frankenbunnies Embryos made by Chinese researchers who fused human skin cells with rabbit eggs, hoping to create a source of stem cells.

Stem cells from breast milk can grow into many other kinds of human tissue, raising hopes of an ethical source of embryonic - like stem cStem cells from breast milk can grow into many other kinds of human tissue, raising hopes of an ethical source of embryonic - like stem cstem cells

Human epidermal equivalents representing different types of skin could also be grown, depending on the source of the stem cells used, and could thus be tailored to study a range of skin conditions and sensitivities in different populations.»

«Our group pioneered the development of cell culture technology for harvesting large numbers of stem cells from human bone marrow and human umbilical cord blood,» Dr. Yeh said, noting that stem cells from these two sources are abundant and can be guided into different types of cells using tissue engineering.

Scientists have created red blood cells from human embryonic stem cells, in a step that they say could mean an infinite source of blood for transfusions.

That still makes them a potential source of ES cells, and because human parthenote embryos can't develop to term, some people have fewer qualms about using them to produce stem cells.

Human pluripotent stem cells from two sources today, one physiological embryonic stem cells «ES» from the embryo, and the other experimental cells «iPS» induced pluripotency by reprogramming genetic somatic cells.

Human Embryonic Stem (hES) cells derived from Preimplantation Genetic Diagnosed (PGD)- embryos offer a new alternative source of cellular model as they can be largely expanded, differentiated in several cell types and harbors «naturally» the causative mutation of the pathology.

For the first time, through the use of human embryonic stem cells (hES) sourced from pre-implantation diagnosis, researchers from Inserm's Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystrostem cells (hES) sourced from pre-implantation diagnosis, researchers from Inserm's Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystroStem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystroStem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystrophy.

Human Prenatal Small Intestine Cells as a Valuable Source of Stem Cells and Epithelial Cells: Phenotypic and Functional Characterization.

Researchers take the first steps towards creating a clinically - relevant source of platelets from human induced pluripotent stem cells.

Since 2005 his group is working on the immunomodulatory activities of human mesenchymal stem cells isolated from different sources — bone marrow, adipose tissue, endometrium, decidua.

We are the home of the UK Stem Cell Bank which provides a world - leading resource of ethically - sourced, quality - controlled human embryonic and other stem cell lines for research applicatiStem Cell Bank which provides a world - leading resource of ethically - sourced, quality - controlled human embryonic and other stem cell lines for research applicatiCell Bank which provides a world - leading resource of ethically - sourced, quality - controlled human embryonic and other stem cell lines for research applicatistem cell lines for research applicaticell lines for research applications.

While human cord blood represents a potentially important source of hematopoietic stem and progenitor cells (HSPC), current two dimensional (2D) growth conditions employed to amplify cell numbers to the level required for many regenerative applications lead to a decline in the absolute percentage of the most primitive HSPCs [1].

The backgrounder below provides summary main points and sources on the position of current NIH Director Dr. Francis Collins in support of human embryonic stem cell research, human cloning, and the creation of ethically - questionable human - animal chimeras.

Researchers have found an unexpected source of stem cells in the adult human brain.

Through May 2013, the CIRM governing board has approved 611 research grants totaling $ 1.822 billion, making CIRM the largest source of funding for human stem cell research in the world.

But, by then, human embryonic stem cells had lost some of their controversial edge, because scientists really had developed an alternative source of cells that reduced the need for material from human embryos.

«This discovery will advance our understanding of stem cell epigenetics and chromatin structures, provide potential mechanisms on maintaining the hallmark properties of ES cells, and help researchers with the rich source of information to better understand some of the unique features — such as self - renewal and pluripotency — of human embryonic stem cells,» said Ng Huck Hui, Ph.D., senior group leader at GIS and a member of the Singapore team that conducted this research.

Labs that derive new human embryonic stem cell lines are few, partly because they can not get financial support from federal sources.

A series of alternative sources of human pluripotent stem cells, perhaps most notably so - called induced pluripotent stem (or iPS) cells, have been increasingly proving their utility.

«In a report published in the journal Lancet, scientists led by Dr. Robert Lanza, chief scientific officer at Advanced Cell Technology, provide the first evidence that stem cells from human embryos can be a safe and effective source of therapies for two types of eye diseases»

However, the further development this type of therapy requires a reliable source for the large amounts of homogenous functional patient - specific NK cells needed and this has led to the generation of NK cells from human induced pluripotent stem cells (iPSCs)[3].

The excitement surrounding cellular reprogramming and the possibility of federal funding for human embryonic stem cell (ESC) research in the US could be overshadowing another promising therapeutic source of stem cells: those derived via parthenogenesis, some researchers say.

In sum, human NSCs represent an invaluable source of cells to investigate human iPS induction, and also represent a potential source of cells for deriving patient - specific pluripotent stem cells for modeling human disease.

The discovery, by scientists at Kyoto University and the University of Wisconsin - Madison, seemed to promise a way out of the bitter debates over embryonic - stem - cell research: rather than using human embryos as a source of stem cells, produce them from adult cells.

«Human Source Of Stem Cells With Potential To Repair Muscle Identified.»

«Finding this population of stem cells in a human source represents a major breakthrough for us because it brings us much closer to a clinical application of this therapy,» said Dr. Huard, the Henry J. Mankin Professor and vice chair for Research in the Department of Orthopaedic Surgery at the University of Pittsburgh School of Medicine.

Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation.

In 1995, Congress banned federal funding for destructive research into human embryos — the source of the most promising type of stem cells.

Less than a year after a Wisconsin team helped discover a major alternative to human embryonic stem cells, the Madison scientists say more than 800 labs have begun using the approach, suggesting that many stem - cell researchers are starting to move beyond controversial embryonic sources for their work.

Review of «Footprint free human iPSCs from articular cartilage with redifferentiation capacity - a first step towards a clinical grade cell source» from Stem Cell Translational Medicine by Stuart P. Atkicell source» from Stem Cell Translational Medicine by Stuart P. AtkiCell Translational Medicine by Stuart P. Atkinson

Human embryonic stem cells (hESCs) could serve as an expandable source for neurons production, which could be applied for the treatment of various diseases affecting brain.

But initial experiments on human fibroblasts from three sources — fetal heart cells, embryonic stem cells and neonatal skin cells — revealed that the GMT combination alone was not sufficient.

Reprogramming by nuclear transfer might provide an important source of pluripotent stem cells from human beings, including patients needing cell therapies.

Contrary to popular belief, stem cells can be harvested from sources other than human embryos, such as body fat and bone marrow (16).

However welcome the recent announcement that a team of scientists based at Newcastle University, has grown a section of human liver using stem cells from umbilical cords, rather than from the more controversial source of embryonic stem cells, and whatever the eventual promise or potential of harvesting organs for transplantation from genetically modified pigs, the benefits of either of these two pioneering techniques to currently dying / suffering patients, remain both elusive and distant.